BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs2230926
,
FABP1
,
Coagulation
,
Pseudomonas infection
,
Endothelial cell
,
Clofibrate
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
SSTR2
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Natural killer cell of peripheral blood
Cerebellum
Superior cervical ganglion
Cerebellum peduncles
Cerebellar hemisphere
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Toxoplasmosis
Brucellosis
Bacterial septicemia
Whipple's disease
Disease caused by rickettsiae
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Octreotide
etofylline
hydroquinone
Botulinum Toxins
Granisetron
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
H2AFB2
SETX
SMARCC2
POLH
OTX2
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
Spatial and temporal expression pattern of somatostatin receptor 2 in mouse].
Metastatic Pheochromocytoma and Paraganglioma: Somatostatin Receptor 2 Expression, Genetics, and The…
Somatostatin receptor 2 in 10 different types of human non-neoplastic gastrointestinal neuroendocrin…
Somatostatin Receptor 2: A Potential Predictive Biomarker for Immune Checkpoint Inhibitor Treatment.
The Wnt pathway protein Dvl1 targets somatostatin receptor 2 for lysosome-dependent degradation.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
177Lu-LNC1010 in SSTR2-positive Tumors
68Ga-FAPI-LM3 PET/CT Imaging in Patients With FAP/SSTR2 Positive Disease and Compared With 18F-FDG
Targeted Alpha-Particle Therapy for Advanced SSTR2 Positive Neuroendocrine Tumors
Optimizing the Interval Between Cycles of PRRT With 177lu-dotatate in sstr2 Positive Tumors
Dual SSTR2 and Integrin αvβ3 Targeting PET/CT Imaging
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ